An open-label, multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer.

被引：2
|
作者：
Moehler, M. H.
Hartmann, J. T.
Lordick, F.
Al-Batran, S.
Reimer, P.
Trarbach, T.
Ebert, M. P.
Daum, S.
Weihrauch, M.
Galle, P. R.
机构：
[1] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany
[2] Christian Albrechts Univ Kiel Klinikum, Kiel, Germany
[3] Klinikum Braunschweig, Med Dept 3, Braunschweig, Germany
[4] Krankenhaus NW Frankfurt, Frankfurt, Germany
[5] Kliniken Essen Sued, Essen, Germany
[6] Univ Duisburg Essen, Dept Med, West German Canc Ctr, Essen, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, Med Dept 2, D-80290 Munich, Germany
[8] Charite, Berlin, Germany
[9] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14503
引用
收藏
页数：1
相关论文
共 50 条
  • [1] An open-label, multicenter biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
    Moehler, M.
    Mueller, A.
    Hartmann, J. T.
    Ebert, M.
    Al-Batran, S-E
    Reimer, P.
    Weihrauch, M.
    Lordick, F.
    Trarbach, T.
    Biesterfeld, S.
    Kabisch, M.
    Wachtlin, D.
    Galle, P. R.
    ONKOLOGIE, 2011, 34 : 103 - 103
  • [2] Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study
    Atkins, Michael B.
    Gravis, Gwenaelle
    Drosik, Kazimierz
    Demkow, Tomasz
    Tomczak, Piotr
    Wong, Shirley S.
    Michaelson, M. Dror
    Choueiri, Toni K.
    Wu, Benjamin
    Navale, Lynn
    Warner, Douglas
    Ravaud, Alain
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (30) : 3431 - +
  • [3] Open-label, phase II, multicenter trial of ZD1839 ('Iressa') in patients with advanced breast cancer.
    Albain, K
    Elledge, R
    Gradishar, WJ
    Hayes, DF
    Rowinsky, E
    Hudis, C
    Pusztai, L
    Tripathy, D
    Modi, S
    Rubi, S
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S33 - S33
  • [4] A multicenter, open-label phase II trial of secondline apatinib plus irinotecan in patients with advanced gastric cancer
    Peng, Jianjun
    Li, Yong
    Xiao, Jianjun
    Liu, Huaqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] Phase II open-label study of sunitinib in patients with advanced breast cancer
    Denise A. Yardley
    E. Claire Dees
    Stephen D. Myers
    Sherry Li
    Paul Healey
    Zhixiao Wang
    Marla J. Brickman
    Jolanda Paolini
    Kenneth A. Kern
    Dennis L. Citrin
    Breast Cancer Research and Treatment, 2012, 136 : 759 - 767
  • [6] Phase II open-label study of sunitinib in patients with advanced breast cancer
    Yardley, Denise A.
    Dees, E. Claire
    Myers, Stephen D.
    Li, Sherry
    Healey, Paul
    Wang, Zhixiao
    Brickman, Marla J.
    Paolini, Jolanda
    Kern, Kenneth A.
    Citrin, Dennis L.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) : 759 - 767
  • [7] Regorafenib in patients with refractory metastatic pancreatic cancer. An open-label phase II study (RESOUND)
    Bozzarelli, S.
    Rimassa, L.
    Giordano, L.
    Sala, S.
    Tronconi, M. C.
    Baretti, M.
    Personeni, N.
    Pressiani, T.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer.
    Bai, Yuxian
    Xu, Jianming
    Sun, Huichuan
    Bai, Chunmei
    Jia, Ru
    Li, Yi
    Zhang, Wenjie
    Liu, Lei
    Huang, Cheng
    Guan, Mei
    Zhou, Jinghong
    Su, Weiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab-refractory metastatic breast cancer.
    Blackwell, KL
    Kaplan, EH
    Franco, SX
    Marcom, PK
    Maleski, JE
    Sorensen, MJ
    Berger, MS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 196S - 196S
  • [10] An open-label trial of SMK treatment of advanced metastatic cancer.
    Hoffman, Steve
    Bruckner, Howard
    Del Priore, Giuseppe
    Gurell, Daniel
    Mull, Ruslan
    Stega, Damian
    Goodwin, Gail
    Demurjian, Mike
    Malanowska-Stega, Jeanetta
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345